Company Filing History:
Years Active: 2003
Title: Kevin Finkel: Innovator in Genetic Research
Introduction
Kevin Finkel is a notable inventor based in Cheshire, CT (US). He has made significant contributions to the field of genetics, particularly through his research on the Angiotensin Receptor 1 (AGTR1) gene. His work has implications for understanding genetic variations in the general population.
Latest Patents
Kevin Finkel holds a patent for "Haplotypes of the AGTR1 gene." This patent describes novel genetic variants of the AGTR1 gene. It discloses various genotypes, haplotypes, and haplotype pairs that exist in the general United States population. Additionally, the patent outlines compositions and methods for haplotyping and/or genotyping the AGTR1 gene in individuals. The polynucleotides defined by the sequence of the haplotypes disclosed are also described in detail. He has 1 patent to his name.
Career Highlights
Kevin Finkel is associated with Genaissance Pharmaceuticals, Inc., where he applies his expertise in genetic research. His work at the company has contributed to advancements in understanding genetic markers and their implications for health.
Collaborations
Throughout his career, Kevin has collaborated with notable colleagues, including Alison E Anastasio and Beena Koshy. These collaborations have further enriched his research and innovation in the field of genetics.
Conclusion
Kevin Finkel's contributions to genetic research, particularly through his patent on the AGTR1 gene, highlight his role as an innovator in the field. His work continues to influence the understanding of genetic variations and their implications for health.